Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp;Warren P. Mason;Martin J. van den Bent;Michael Weller.
The New England Journal of Medicine (2005)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp;Monika E. Hegi;Warren P. Mason;Martin J. van den Bent.
Lancet Oncology (2009)
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot;Wolfgang Wick;Warren Mason;Roger Henriksson.
The New England Journal of Medicine (2014)
Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
Martin J. van den Bent;Alba A. Brandes;Martin J.B. Taphoorn;Johan M. Kros.
Journal of Clinical Oncology (2013)
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Roger Stupp;Roger Stupp;Monika E Hegi;Thierry Gorlia;Sara C Erridge.
Lancet Oncology (2014)
Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial
Martin J. van den Bent;Antoine F. Carpentier;Alba A. Brandes;Marc Sanson.
Journal of Clinical Oncology (2006)
MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients
Alba A. Brandes;Enrico Franceschi;Alicia Tosoni;Valeria Blatt.
Journal of Clinical Oncology (2008)
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Michael Weller;Roger Stupp;Guido Reifenberger;Alba A. Brandes.
Nature Reviews Neurology (2010)
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
James R. Perry;Normand Laperriere;Christopher J. O'Callaghan;Alba A. Brandes.
The New England Journal of Medicine (2017)
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.
Andrés J. M. Ferreri;Michele Reni;Marco Foppoli;Maurizio Martelli.
The Lancet (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Erasmus University Rotterdam
German Cancer Research Center
Northwestern University
University of Zurich
Erasmus University Rotterdam
Vita-Salute San Raffaele University
University of Western Australia
University of Bologna
University of Lausanne
Université Paris Cité
Carnegie Mellon University
City University of Hong Kong
Heinrich Heine University Düsseldorf
University of South Carolina
University of Bristol
University of Siena
Icahn School of Medicine at Mount Sinai
University of Montpellier
University of Copenhagen
Amherst College
University of Wuppertal
University of Pittsburgh
University of Oregon
University of North Carolina at Chapel Hill
University of California, Los Angeles
University of Milan